Deterioration in the health-related quality of life of persons with multiple sclerosis: The possible warning signs

Multiple Sclerosis

Volumn 13, Issue 8, 2007, Pages 1038-1045

  Turpin, Karen V L ^a   Carroll, L J ^a   Cassidy, J D ^b,d   Hader, W J ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Comorbid conditions; Health related quality of life; Illness intrusiveness; Multiple sclerosis

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BECK DEPRESSION INVENTORY; CANADA; CLINICAL ASSESSMENT TOOL; COMORBIDITY; DEPRESSION; DISABILITY; DISEASE ASSOCIATION; EXPANDED DISABILITY STATUS SCALE; FATIGUE; FEMALE; GENITAL SYSTEM DISEASE; HEADACHE; HUMAN; ILLNESS INTRUSIVENESS RATING SCALE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MULTIPLE SCLEROSIS; MUSCULOSKELETAL DISEASE; QUALITY OF LIFE; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE; SELF REPORT; SEX DIFFERENCE; SHORT FORM 36; SOCIAL STATUS; URINARY TRACT DISEASE; AGED; ATTITUDE TO HEALTH; EMPLOYMENT; HEALTH STATUS; HOSPITALIZATION; MIDDLE AGED; NATIONAL HEALTH SERVICE; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; SOCIOECONOMICS;

ADULT; AGED; ATTITUDE TO HEALTH; DEPRESSION; EMPLOYMENT; FATIGUE; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; QUALITY OF LIFE; SASKATCHEWAN; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; STATE MEDICINE;

EID: 38449112951     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458507078393     Document Type: Article

References (72)

1. Warren S, Warren KG. Mult Scler. World Health Organization, 2001.
2. Chang C-H, Cella D, Fernaández O, Luque G, de Castro P, de Andrés C, Casanova B, Hernández MA, Prieto JM, Fernández VE, de Ramón E. Quality of life in multiple sclerosis patients in Spain. Mult Scler 2002; 8: 527-31.
3. Merkelbach S, Sittinger H, Koenig J. Is there a differential impact of fatigue and physical disability on quality of life in multiple sclerosis? J Nerv Ment Dis 2002; 190: 388-93.
4. Shawaryn MA, Schiaffino KM, LaRocca NG, Johnston MV. Determinants of health-related quality of life in multiple sclerosis: the role of illness intrusiveness. Mult Scler 2002; 8: 310-18.
5. Solari A, Filippini G, Mendozzi L, Ghezzi A, Cifani S, Barbierj E et al. Validation of Italian multiple sclerosis quality of life 54 questionnaire. J Neurol Neurosur Ps 1999; 67: 158-62.
6. Singer MA, Hopman WM, MacKenzie TA. Physical functioning and mental health in patients with chronic medical conditions. Quality of Life Research 1999; 8: 687-91.
7. Roberts G, Stuifbergen AK. Health appraisal models in multiple sclerosis. Soc Sci Med 1998; 47: 243-53.
8. Hakim EA, Bakheit AMO, Bryant TN, Roberts MWH, McIntosh-Michaels SA, Spackman AJ et al. The social impact of multiple sclerosis - a study of 305 patients and their relatives. Disabil Rehabil 2000; 22: 288-93.
9. Aronson KJ. Quality of life among persons with multiple sclerosis and their caregivers. Neurology 1997; 48: 74-80.
10. Koch LC, Rumrill PD Jr. Illness and demographic correlates of quality of life among people with multiple sclerosis. Rehabil Psychol 2001; 46: 154-64.
11. Lankhorst GJ, Jelles F, Smits RCF, Polman CH, Kuik DJ, Pfennings LEMA et al. Quality of life in multiple sclerosis: the disability and impact profile (DIP). J Neurol 1996; 243: 469-74.
12. Rudick RA, Miller D, Clough JD, Gragg LA, Farmer RG. Quality of life in multiple sclerosis: comparison with inflammatory bowel disease and rheumatoid arthritis. Arch Neurol 1992; 49: 1237-42.
13. Solari A, Radice D. Health status of people with multiple sclerosis: A community mail survey. Neurol Sci 2001; 22: 307-15.
14. Vickery BG, Hays RD, Harooni R, Myers LW, Ellison GW. A health-related quality of life measure for multiple sclerosis. Qual Life Res 1995; 4: 187-206.
15. Amato MP, Ponziani G, Rossi F, Liedl CL, Stefanile C, Rossi L. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler 2001; 7: 340-44.
16. Janardhan VBR. Quality of life in patients with multiple sclerosis: The impact of fatigue and depression. J Neurol Sci 2002; 205: 51-58.
17. Jønsson A, Dock J, Ravnborg MH. Quality of life as a measure of rehabilitation outcome in patients with multiple sclerosis. Acta Neurol Scand 1996; 93: 229-35.
18. Nortvedt MW, Riise T. The use of quality of life measures in multiple sclerosis research. Mult Scler 2003; 9: 63-72.
19. Benito-León J, Morales JM, Rivera-Navarro J. Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis. Eur J Neurol 2002; 9: 497-502.
20. Cutajar R, Ferriani E, Scandellari C, Sabattini L, Trocino C, Marchello LP et al. Cognitive function and quality of life in multiple sclerosis patients. J Neurovirol 2000; 6: S186-S90.
21. Fruehwald S, Loeffler-Stastka H, Eher R, Saletu B, Baumhackl U. Depression and quality of life in multiple sclerosis. Acta Neurol Scand 2001; 104: 257-61.
22. Kenealy PM, Beaumont JG, Lintern R, Murrell R. Autobiographical memory, depression and quality of life in multiple sclerosis. J Clin Exp Neuropsyc 2000; 22: 125-31.
23. Nicholl CR, Lincoln NB, Francis VM, Stephan TF. Assessing quality of life in people with multiple sclerosis. Disabil Rehabil 2001; 23: 597-603.
24. Patti F, Cacopardo M, Palermo F, Ciancio MR, Lopes R, Restivo D et al. Health-related quality of life and depression in an Italian sample of multiple sclerosis patients. J Neurol Sci 2003; 211: 55-62.
25. Provinciali L, Ceravolo MG, Bartolini M, Logullo F, Danne MA. A multidimensional assessment of multiple sclerosis: relationships between disability domains. Acta Neurol Scand 1999; 100: 156-62.
26. The Canadian Burden of Illness Study Group. Burden of illness of multiple sclerosis: part II: quality of life. Can J Neurol Sci 1998; 25: 31-38.
27. Wang JL, Reimer MA, Metz LM, Patten SB. Major depression and quality of life in individuals with multiple sclerosis. Int J Psych Med 2000; 30: 309-17.
28. Grima DT, Torrance GW, Francis G, Rice G, Rosner AJ, Lafortune L. Cost and health-related quality of life consequences of multiple sclerosis. Mult Scler 2000; 6: 91-98.
29. Henriksson F, Fredrikson S, Masterman T, Jönsson B. Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden. Eur J Neurol 2001; 8: 27-35.
30. Parkin D, Jacoby A, McNamee P, Miller P, Thomas S, Bates D. Treatment of multiple sclerosis with interferon β: an appraisal of cost-effectiveness and quality of life. J Neurol Neurosur Psych 2000; 68: 144-49.
31. Rice GP, Oger J, Duquette O, Francis GS, Bélanger M, Laplante S, Grenier JF. Treatment with interferon beta-1b improves quality of life in multiple sclerosis. Can J Neurol Sci 1999; 26: 276-82.
32. Somerset M, Peters TJ, Sharp DJ, Campbell R. Factors that contribute to quality of life outcomes prioritised by people with multiple sclerosis. Quality of Life Research 2003; 12: 21-29.
33. Brunet DG, Hopman WM, Singer MA, Edgar CM, MacKenzie TA. Measurement of health-related quality of life in multiple sclerosis patients. Can J Neurol Sci 1996; 23: 99-103.
34. Ford HL, Gerry E, Johnson MH, Tennants A. Health status and quality of life of people with multiple sclerosis. Disabil Rehabil 2001; 23: 516-21.
35. Janardhan B, Bakshi R. Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis. Arch Neurol 2000; 57: 1485-91.
36. Miller DM, Rudick RA, Baier M, Cutter G, Doughtery DS, Weinstock-Guttman B et al. Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis. Mult Scler 2003; 9: 1-5.
37. Modrego PJ, Pina MA, Simón A, Azuara MC. The interrelations between disability and quality of life in patients with multiple sclerosis in the area of Bajo Aragon, Spain: a geographically based survey. Neurorehab Neural Re 2001; 15: 69-73.
38. Murphy N, Confavreux C, Haas J, König N, Roullet E, Sailer M et al. Quality of life in multiple sclerosis in France, Germany, and the United Kingdom. J Neurol Neurosur Psych 1998; 65: 460-66.
39. Nortvedt MW, Riise T, Myhr KM, Nyland HI. Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurol 1999; 53: 1098-103.
40. Nortvedt MW, Riise T, Myhr K-M, Nyland HI. Performance of the SF-36, SF-12, and RAND-36 Summary Scales in a multiple sclerosis population. Medical Care 2000; 38: 1022-28.
41. Nortvedt MW, Riise T, Myhr K-M, Nyland HI. Quality of life as a predictor for change in disability in MS. American Academy of Neurology 2000; 55: 51-54.
42. O'Connor P, Lee L, Tin Ng P, Narayana P, Wolinsky JS. Determinants of overall quality of life in secondary progressive MS: a longitudinal study. Neurol 2001; 57: 889-91.
43. Pfennings L, Cohen L, Adèr H, Polman C, Lankhorst G, Smits R et al. Exploring differences between subgroups of multiple sclerosis patients in health-related quality of life. J Neurol 1999; 246: 587-91.
44. Stuifbergen AR, Seraphine A, Roberts G. An explanatory model of health promotion and quality of life in chronic disabling conditions. Nursing Research 2000; 49: 122-29.
45. Vermersch P, de Seze J, Delisse B, Lemaire S, Stojkovic T. Quality of life in multiple sclerosis: influence of interferon-β1a (Avonexρ) treatment. Mult Scler 2002; 8: 377-81.
46. Somerset M, Sharp D, Campbell R. Multiple sclerosis and quality of life: a qualitative investigation. J Health Serv Res 2002; 7: 151-59.
47. Rothwell PM, McDowell Z, Wong CK, Dorman PJ. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. British Medical Journal 1997; 314: 1580-83.
48. Arnoldus JH, Killestein J, Pfennings LE, Jelles B, Uitdehaag BM, and Polman CH. Quality of life during the first 6 months of interferon-beta treatment in patients with MS. Mult Scler 2000; 6: 338-42.
49. Ware JE, Snow KR, Kosiuski M, Gandek B. SF-36 health survey: manual and interpretation guide. The Health Institute, New England Medical Centre, 1993.
50. McHorney CA, Ware JE, Raczek AE. The MOS 36-item short-form health survey (SF-36): II. psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care 1993; 31: 247-63.
51. McHorney CA, Ware JE, Lu. R. Sherbourne DC. The MOS 36-item short-form health survey (SF-36): III. tests of data quality, scaling assumptions, and reliability across diverse patient groups. Medical Care 1994; 32: 40-66.
52. Hopman WM, Towheed T, Anastassiades T, Tenenhouse A, Poliquin S, Berger C et al. The Canadian Multicentre Osteoporosis Study Research Group. Canadian normative data for the SF-36 health survey. Can Med Assoc J 2000; 163: 265-71.
53. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol 1988; 45: 435-37.
54. Beck AT. Depression: clinical, experimental, and theoretical aspects. Hoeber Medical Division, Harper and Row, 1967.
55. Carroll LJ, Cassidy JD, Côté P. The Saskatchewan health and back pain survey: the prevalence and factors associated with depressive symptomatology in Saskatchewan adults, Can J Public Health 2000; 91: 459-64.
56. Carroll LJ, Mercado AC, Cassidy JD, Côté P. A population-based study of factors associated with combinations of active and passive coping with neck and low back pain. J Rehabil Med 2002; 34: 67-72.
57. Carroll LJ, Cassidy JD, Côté P. Depression as a risk factor for onset of an episode of troublesome neck and low back pain. Pain 2004; 107: 134-39.
58. Côté P, Cassidy J, Carroll L. Is lifetime history of neck injury in a traffic collision associated with prevalent neck pain, headache and depressive symptomatology? Accid Anal Prev 2000; 32: 151-59.
59. Côte P, Cassidy J, Carroll L. The factors associated with neck pain and its related disability in the Saskatchewan population. Spine 2000; 25: 1109-17.
60. Côt ̧P, Cassidy JD, Carroll LJ. The treatment of spinal pain: who seeks care? Who goes where? Medical Care 2001; 39: 956-67.
61. Jaroszynski G, Cassidy JD, Carroll LJ, Côté P, Yong-Hing K. Development and validation of a comorbidity scale Quebec, 1996.
62. Mercado AC, Carroll LJ, Cassidy JD, Côtéi P. Coping with neck and low back pain in the general population. Health Psychology 2000; 19: 333-38.
63. Devins GM, Binik YM, Hutchinson TA, Hollomby DJ, Barre PE, Guttmann RD. The emotional impact of end-stage renal disease: importance of patients' perception of intrusiveness and control. Int J Psych Med 1983-1984; 13: 327-43.
64. Devins GM, Seland TP. Emotional impact of multiple sclerosis: recent findings and suggestions for future research. Psychological Bulletin 1987; 101: 363-75.
65. Devins GM, Edworthy SM, Paul LC, Mandin H, Seland TP, Klein G et al. Restless sleep, illness intrusiveness, and depressive symptoms in three chronic illness conditions: rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. J Psych Res 1993; 37: 163-70.
66. Devins GM, Edworthy SM, Seland TP, Klein GM, Paul LC, Mandin H. Differences in illness intrusiveness across rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. J Nerv Ment Dis 1993; 181: 377-81.
67. Devins GM, Seland TP, Klein G, Edworthy S, Saary MJ. Stability and determinants of psychosocial well-being in multiple sclerosis. Rehabil Psychol 1993; 38: 11-26.
68. Flanagan JC. Measurement of quality of life: current state of the art. Arch Phys Med Rehabil 1982; 63: 56-59.
69. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurol 1983; 33: 1444-52.
70. O'Connor P. Multiple sclerosis: the facts you need. Key Porter Books, 2002.
71. Halper J. Advanced concepts in multiple sclerosis nursing care. Demos Medical Publishing Inc., 2001.
72. Gulick EE. Correlates of quality of life among persons with multiple sclerosis. Nurs Res 1997; 46: 305-11.